InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-20.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Nash Duane, Président Exécutif. Insider active across 1 company, notably Immunic, INC.. Aggregated, 4 filings have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €113k. Activity tracked since 12 May 2021. The latest transaction was disclosed on 13 June 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Nash Duane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
20,000 shares@ US$0.834712.7% of flowCommon StockSEC:0001193805-25-000885:0
Canonical exit: 11 Sept 2025 (T+90)
10,000 shares@ US$5.030.029% mcap32.4% of flowCommon StockSEC:0001193805-22-000787:0
Canonical exit: 10 Aug 2022 (T+90)
1,000 shares@ US$9.807.4% of flowCommon StockSEC:0001193805-21-001159:0
Canonical exit: 8 Nov 2021 (T+90)
4,000 shares@ US$12.7537.2% of flowCommon StockSEC:0001193805-21-000654:0
Canonical exit: 10 Aug 2021 (T+90)
4 of 4 declarations
About Nash Duane
Duane Nash is the Executive Chairman at Immunic, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing operations. His experience is valuable for the development of Immunic.
